Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Bob Trocchi who wrote (17707)	3/16/1999 5:18:00 PM
From: larry	Respond to of 18691

...But I hate to see MSFT making moves right now instead of next week! I was expecting the issue to close at 165 for the option expiration this Friday and load up more next Monday. Now it looks like that it will close at 170, even 175 by Friday. I want more MSFT, but then I will have to sell AOL, a real winner. This is really getting shitty.:( But we will have another 10 easy points next week for sure. If we take out the old high by next Friday, it should gap up 4 points (presplit) on March 29th. good luck, larry!

To: Bob Trocchi who wrote (17707)	3/22/1999 9:13:00 PM
From: BDR	Read Replies (2) \| Respond to of 18691

Re: ZONA, et al. I was scanning the abstracts to be presented at the national AUA meeting the first week of May and counted the number of abstract titles that mentioned various impotence treatments. For the products currently on the market here in the U.S. or other countries the results are: Sildenafil(Viagra).........15 Alprostadil (MUSE)..........4 Injections(Edex or other)...2 Phentolamine(Vasomax)......Zero Looks like Vasomax is not exactly a focus of intense research activity. Other modalities mentioned: Apomorphine................3 Gene therapy...............2 Melanotan II...............1 Potassium channel opener...1 IC351......................1 Results subject to error due to my inability to add correctly. Disclaimer: I am long Pfizer, short ZONA and I couldn't care less about VVUS.